NDC Package 0430-0970-00 Risedronate Sodium

Tablet, Delayed Release - View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0430-0970-00
Package Description:
22792 TABLET, DELAYED RELEASE in 1 DRUM
Product Code:
Non-Proprietary Name:
Risedronate Sodium
Substance Name:
Risedronate Sodium Hemi-pentahydrate; Risedronate Sodium Monohydrate
Usage Information:
Risedronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). Risedronate belongs to a class of medications called bisphosphonates.
11-Digit NDC Billing Format:
00430097000
Product Type:
Drug For Further Processing
Labeler Name:
Allergan, Inc.
Dosage Form:
Tablet, Delayed Release - A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
12-01-2010
Listing Expiration Date:
12-31-2024
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0430-0970-00?

The NDC Packaged Code 0430-0970-00 is assigned to an UNFINISHED drug package of 22792 tablet, delayed release in 1 drum of Risedronate Sodium, drug for further processing labeled by Allergan, Inc.. The product's dosage form is tablet, delayed release and is administered via form.

Is NDC 0430-0970 included in the NDC Directory?

Yes, Risedronate Sodium is an UNFINISHED PRODUCT with code 0430-0970 that is active and included in the NDC Directory. The product was first marketed by Allergan, Inc. on December 01, 2010 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 0430-0970-00?

The 11-digit format is 00430097000. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
4-4-20430-0970-005-4-200430-0970-00